Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$43.66 - $61.0 $174,640 - $244,000
4,000 New
4,000 $215,000
Q2 2022

Aug 12, 2022

SELL
$28.82 - $77.35 $126,808 - $340,340
-4,400 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$88.71 - $120.43 $390,324 - $529,892
4,400 New
4,400 $440,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.